Glycemic Variability and Control by CGM in Healthy Older and Young Adults and Their Relationship With Diet
Anika Köhlmoos1, Manuela Dittmar1
1Human Biology, Zoological Institute, Christian-Albrechts-University, Kiel 24118, Germany.
Abstract:
Continuous glucose monitoring (CGM) might be beneficial for investigating healthy aging since high glycemic variability may increase protein glycation, oxidative stress, and inflammation, resulting in vascular damage. Additionally, CGM data on the risks for hypoglycemia and hyperglycemia are scarce, have not been analyzed by individual day and night blocks, and have not been related to diet. Therefore, this study aimed to compare glucose parameters of healthy older and young adults and the relationship with diet. Participants were 34 young (age 20-35 years) and 27 older volunteers (age 60-75 years) with a normal glycated hemoglobin A1c less than 39 mmol/mol hemoglobin, free of disorders and medication. Twenty-four CGM-derived glucose parameters measured over 5 consecutive days were analyzed for whole days and for individual daytime and nighttime blocks. Dietary intake was determined by 3-day dietary record. Neither intraday nor interday glycemic variability differed between the healthy age groups. Glycemic control was good in both age groups, but somewhat poorer in older adults. The risk of hyperglycemia was higher and of hypoglycemia lower in older adults. During the daytime, mean and minimum glucose were higher in older adults. During the nighttime, age group differences were small. The carbohydrate intake correlated positively with glycemic variability in both age groups. The protein intake correlated positively with the hypoglycemic risk in young adults, but negatively in older adults. Results suggest that healthy aging does not increase glycemic variability and the risk of hypoglycemia. The effect of diet on hypoglycemic and hyperglycemic risk might change with aging.
More Related Videos
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
